Includes bibliographical references and index.

Online resource; title from PDF title page (EBSCO, viewed July 7, 2015).

Front Cover; Medicinal Plants: Chemistry, Biology and Omics; Copyright; Contents; Preface; Five features of this book; Chapter authorship; About the authors; Chapter 1: Chemotaxonomy: a phylogeny-based approach; 1.1. Introduction; 1.2. Chemotaxonomic marker; 1.2.1. Primary metabolite; 1.2.1.1. Fatty acid; 1.2.1.2. Protein, amino acid, and carbohydrate; 1.2.1.3. Alkanes; 1.2.1.4. Alkynes; 1.2.1.5. Carotenoid; 1.2.2. Secondary metabolite; 1.2.2.1. Essential oil and volatile terpene; 1.2.2.2. Sesquiterpene; 1.2.2.3. Diterpene; 1.2.2.4. Triterpene saponin; 1.2.2.5. Phenolic compound.

1.2.2.6. Flavonoid1.2.2.7. Quinone; 1.2.2.8. Alkaloid; 1.2.2.9. Lignan; 1.2.2.10. Glucosinolate; 1.2.2.11. Glycoside; 1.2.3. Macroelement and trace element; 1.3. Metabolomics; 1.3.1. Asterids of core eudicot; 1.3.2. Rosids of core eudicot; 1.3.3. Other eudicots; 1.3.4. Gymnosperm; 1.3.5. Bryophyte; 1.4. Cheminformatics and database; 1.5. Chemotype; 1.5.1. Flower; 1.5.2. Fruit; 1.5.3. Root; 1.5.4. Bulb; 1.6. Conclusions; References; Chapter 2: High-throughput sequencing in medicinal plant transcriptome studies; 2.1. Introduction; 2.2. Metabolic pathway analysis; 2.2.1. Terpenoid and saponin.

2.2.2. Saponin2.2.3. Flavonoids and phenolics; 2.2.4. Alkaloids; 2.2.5. Glucosinolate; 2.2.6. Polyketide; 2.2.7. CYPs; 2.2.8. Glycosyltransferase; 2.2.9. Other enzymes; 2.2.10. Regulation; 2.2.11. Integrated use of omics platform; 2.3. Molecular marker mining; 2.3.1. Simple sequence repeats; 2.3.1.1. Flower; 2.3.1.2. Fruit; 2.3.1.3. Seedling; 2.3.2. Single nucleotide polymorphisms; 2.3.2.1. Root; 2.3.2.2. Seed; 2.3.2.3. Inflorescence; 2.4. Adaptation and plant development; 2.4.1. Flower; 2.4.2. Stem; 2.4.3. Seed; 2.4.4. Fruit; 2.4.5. Leaf; 2.4.6. Root; 2.4.7. Turion.

2.5. Comparative transcriptomics and phylogeny2.5.1. Bioinformatics; 2.5.2. Asterids of eudicot; 2.5.3. Rosids of eudicot; 2.5.4. Other eudicots; 2.5.5. Gymnosperm; 2.5.6. Moss and other lower plants; 2.6. Digital gene expression; 2.7. Conclusion; References; Chapter 3: Taxus medicinal resources: a comprehensive study; 3.1. Introduction; 3.2. From molecular biology to genomics; 3.2.1. Molecular phylogeny, taxonomy, and evolution; 3.2.2. Genomics and transcriptomics; 3.2.2.1. Genomics; 3.2.2.2. Transcriptomics; 3.2.2.3. Molecular marker; 3.2.2.4. Microbe.

3.3. Bioactivity, pharmacology, and therapeutic use3.3.1. Anticancer activity; 3.3.2. Effects on the cardiovascular system; 3.3.3. Effects on the nervous system; 3.3.4. Anti-inflammatory and analgesic activities; 3.3.5. Other effects; 3.3.6. Toxicity and side effects; 3.4. From chemistry to metabolomics; 3.4.1. Taxane diterpenoids; 3.4.2. Alkaloids; 3.4.3. Other compounds; 3.4.4. Chemotaxonomy; 3.4.5. Metabolomics and functional genomics; 3.5. Proteomics; 3.6. Bibliometric analysis of Taxus research; 3.7. Conclusion and prospects; Acknowledgments; References.

Medicinal Plants: Chemistry, Biology and Omics reviews the phytochemistry, chemotaxonomy, molecular biology, and phylogeny of selected medicinal plant tribes and genera, and their relevance to drug efficacy. Medicinal plants provide a myriad of pharmaceutically active components, which have been commonly used in traditional Chinese medicine and worldwide for thousands of years. Increasing interest in plant-based medicinal resources has led to additional discoveries of many novel compounds, in various angiosperm and gymnosperm species, and investigations on their chemotaxonomy, molecular ph.